All articles by Vidya Sagar Maddela
ZayaAI Partners with Enjinstarter to Transform Healthcare with AI and Blockchain Integration
ZayaAI equips pathologists and researchers in clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses.
Thermo Fisher partners with NCI to support myeloMATCH study
Thermo Fisher will provide its next-generation sequencing (NGS) technology, which will help researchers test patients’ bone marrow and blood for certain genetic biomarkers, to rapidly match patients with a relevant clinical trial
Element Bio raises $277m to advance its DNA sequencing solutions
Element intends to use the funding for the marketing of its AVITI benchtop DNA sequencing solution and support the upcoming launch of AVITI24, which combines advanced sequencing and cyto-profiling into a single platform
Koning Health Brings Advanced Breast Imaging Technology to Bedford Breast Center in Beverly Hills
Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Vera Breast CT (KBCT)
EnsoData acquires sleep apnea diagnostic technology from Resonea
With the acquisition, EnsoData will add new acoustic flow and microphone channels that enable pre-screening of patients for sleep apnea using an FDA-approved mobile app, extending the diagnostic capabilities of home sleep testing
Babson Diagnostics Launches BetterWay Across Austin
BetterWay brings a true alternative to traditional blood testing with affordable, convenient, and accurate testing in retail pharmacies.
XyloCor licenses SmartCella’s Extroducer Infusion Catheter System
XyloCor will obtain a global license to use the Extroducer Infusion Catheter System to support the catheter-based endocardial delivery of its lead gene therapy candidate, XC001
Paragon Genomics taps Biosecure ID to distribute CleanPlex in UK and Ireland
CleanPlex is an ultra-high multiplexed target enrichment technology that provides single-cell level direct amplification sensitivity and makes it possible to include a large number of genomic targets in a single assay
Aktiia partners with Lindus to study its BP monitoring device
Lindus Health will provide protocol development, regulatory submissions, recruitment, monitoring, and data management, and will use its in-house virtual site and digital marketing capabilities for the study
Octagos Health Secures Over $43 Million Investment to Advance AI-Driven Cardiac Device Monitoring
Octagos Health is a leading provider of cardiac monitoring solutions, dedicated to improving patient outcomes through advanced technology and comprehensive monitoring services